39 related articles for article (PubMed ID: 14706491)
1. A fast visual evoked potential method for functional assessment and follow-up of childhood optic gliomas.
Trisciuzzi MT; Riccardi R; Piccardi M; Iarossi G; Buzzonetti L; Dickmann A; Colosimo C; Ruggiero A; Di Rocco C; Falsini B
Clin Neurophysiol; 2004 Jan; 115(1):217-26. PubMed ID: 14706491
[TBL] [Abstract][Full Text] [Related]
2. Effects of Memantine on the Auditory Steady-State and Harmonic Responses to 40 Hz Stimulation Across Species.
Swerdlow NR; Gonzalez CE; Raza MU; Gautam D; Miyakoshi M; Clayson PE; Joshi YB; Molina JL; Talledo J; Thomas ML; Light GA; Sivarao DV
Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 Mar; 9(3):346-355. PubMed ID: 37683728
[TBL] [Abstract][Full Text] [Related]
3. Visual evoked potential evaluation following brain injury in school-aged children.
Verejan V
Rom J Ophthalmol; 2024; 68(1):19-24. PubMed ID: 38617718
[No Abstract] [Full Text] [Related]
4. The Neuroimmune Regulation and Potential Therapeutic Strategies of Optic Pathway Glioma.
Irshad K; Huang YK; Rodriguez P; Lo J; Aghoghovwia BE; Pan Y; Chang KC
Brain Sci; 2023 Oct; 13(10):. PubMed ID: 37891793
[TBL] [Abstract][Full Text] [Related]
5. Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers.
Meco D; Attinà G; Mastrangelo S; Navarra P; Ruggiero A
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674870
[TBL] [Abstract][Full Text] [Related]
6. The role of visual electrodiagnostics in management of children with neurofibromatosis type 1.
Tekavčič Pompe M; Pečarič Meglič N; Šuštar Habjan M
Doc Ophthalmol; 2023 Apr; 146(2):121-136. PubMed ID: 36652041
[TBL] [Abstract][Full Text] [Related]
7. Temozolomide and oral etoposide in children with recurrent malignant brain tumors.
Ruggiero A; Ariano A; Triarico S; Capozza MA; Romano A; Maurizi P; Mastrangelo S; Attinà G
Drugs Context; 2020; 9():. PubMed ID: 32547627
[TBL] [Abstract][Full Text] [Related]
8. Multifocal infantile haemangiomatosis with hepatic involvement: two cases and treatment management.
Ruggiero A; Maurizi P; Triarico S; Capozza MA; Mastrangelo S; Attinà G
Drugs Context; 2020; 9():. PubMed ID: 32256632
[TBL] [Abstract][Full Text] [Related]
9. Central and peripheral steady-state visual evoked potentials in children with optic pathway gliomas.
Rassi SZ; Ospina LH; Bochereau A; Samson Y; Perreault S; Saint-Amour D
Doc Ophthalmol; 2019 Oct; 139(2):137-149. PubMed ID: 31243619
[TBL] [Abstract][Full Text] [Related]
10. Visual function assessed by visually evoked potentials in optic pathway low-grade gliomas with and without neurofibromatosis type 1.
Dotto PF; Berezovsky A; Cappellano AM; da Silva NS; Sacai PY; Silva FAB; Fernandes AG; Rocha DM; Salomão SR
Doc Ophthalmol; 2018 Jun; 136(3):177-189. PubMed ID: 29766345
[TBL] [Abstract][Full Text] [Related]
11. Renal toxicity and chemotherapy in children with cancer.
Ruggiero A; Ferrara P; Attinà G; Rizzo D; Riccardi R
Br J Clin Pharmacol; 2017 Dec; 83(12):2605-2614. PubMed ID: 28758697
[TBL] [Abstract][Full Text] [Related]
12. Hypersensitivity to Carboplatin in Children with Malignancy.
Ruggiero A; Rizzo D; Catalano M; Attinà G; Riccardi R
Front Pharmacol; 2017; 8():201. PubMed ID: 28446876
[No Abstract] [Full Text] [Related]
13. Rechallenge to Carboplatin in Children with Low Grade Glioma and Carboplatin Hypersensitivity Reactions.
Ruggiero A; Rizzo D; Catalano M; Maurizi P; Mastrangelo S; Attinà G; Riccardi R
Front Pharmacol; 2017; 8():179. PubMed ID: 28439238
[No Abstract] [Full Text] [Related]
14. Handheld optical coherence tomography during sedation in young children with optic pathway gliomas.
Avery RA; Hwang EI; Ishikawa H; Acosta MT; Hutcheson KA; Santos D; Zand DJ; Kilburn LB; Rosenbaum KN; Rood BR; Schuman JS; Packer RJ
JAMA Ophthalmol; 2014 Mar; 132(3):265-71. PubMed ID: 24435762
[TBL] [Abstract][Full Text] [Related]
15. Role of visual evoked potentials in the assessment and management of optic pathway gliomas in children.
Van Mierlo C; Spileers W; Legius E; Casteels I; Cassiman C
Doc Ophthalmol; 2013 Dec; 127(3):177-90. PubMed ID: 23884797
[TBL] [Abstract][Full Text] [Related]
16. Retinal nerve fiber layer thickness in children with optic pathway gliomas.
Avery RA; Liu GT; Fisher MJ; Quinn GE; Belasco JB; Phillips PC; Maguire MG; Balcer LJ
Am J Ophthalmol; 2011 Mar; 151(3):542-9.e2. PubMed ID: 21232732
[TBL] [Abstract][Full Text] [Related]
17. The exact estimation of visual acuity by VEP technology: a report of 726 cases of eye injury.
Rao G; Wu B; Zhang L
J Huazhong Univ Sci Technolog Med Sci; 2010 Feb; 30(1):138-40. PubMed ID: 20155471
[TBL] [Abstract][Full Text] [Related]
18. Optic nerve dysfunction in a mouse model of neurofibromatosis-1 optic glioma.
Hegedus B; Hughes FW; Garbow JR; Gianino S; Banerjee D; Kim K; Ellisman MH; Brantley MA; Gutmann DH
J Neuropathol Exp Neurol; 2009 May; 68(5):542-51. PubMed ID: 19525901
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal assessment of childhood optic gliomas: relationship between flicker visual evoked potentials and magnetic resonance imaging findings.
Falsini B; Ziccardi L; Lazzareschi I; Ruggiero A; Placentino L; Dickmann A; Liotti L; Piccardi M; Balestrazzi E; Colosimo C; Di Rocco C; Riccardi R
J Neurooncol; 2008 May; 88(1):87-96. PubMed ID: 18246407
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
